The global pulse electromagnetic field therapy devices market size is estimated to reach USD 784.0 million by 2030, registering to grow at a CAGR of 6.0% from 2024 to 2030 according to a new report by Grand View Research, Inc. Increasing focus on the development of advanced products is expected to boost the market growth. Furthermore, increasing cases of sports injuries and road accidents are expected to boost the demand for these devices, thereby augmenting the market growth. For instance, according to the WHO, about 1.3 million people die every year due to road traffic crashes.
Strict lockdown restrictions have been put in place across various regions to limit the spread of the COVID-19 disease. With travel restrictions, quarantine as well as complete lockdowns in several countries, the economy has been slackened down and is moving into a state of recession. This has also included the healthcare systems across the globe. Furthermore, the COVID-19 pandemic affected traumatology and orthopedics, wherein nonurgent consultations were canceled and elective surgeries were postponed to reduce the risk of infection for medical staff as well as patients. Hence, the pandemic created a negative impact on the market growth.
The U.S. FDA has approved pulse electromagnetic fields (PEMFs) as an effective and safe treatment for nonunion of bone. After the FDA approval, the product usage for bone repair has increased in Europe as well as in the U.S., fostering the overall market growth. Also, numerous studies have reported that the efficacy of these devices in treating nonunion fractures, with the healing rate, ranges from 68% to 90%. Earlier in vivo and in vitro studies demonstrated that the application of PEMF therapy increased the expression of growth factors and improved the local environment to facilitate the bone healing process.
Request a free sample copy or view report summary: Pulse Electromagnetic Field Therapy Devices Market Report
Low frequency PEMF devices dominated with a 60.2% market share in 2023. These devices have gained significant traction due to their effectiveness in providing therapeutic benefits with minimal side effects.
Pain management applications dominated the market in 2023. The surge was primarily stimulated by the rising prevalence of chronic pain conditions such as arthritis, fibromyalgia, and lower back pain.
Hospitals accounted for the dominant market share of 50.8% in 2023 owing to the rising prevalence of chronic pain and musculoskeletal disorders.
The North America pulse electromagnetic field therapy devices market dominated with a 41.4% share in 2023.
Grand View Research has segmented the global pulse electromagnetic field therapy devices market based on power, application, end-use, and region:
Pulse Electromagnetic Field Therapy Devices Power Outlook (Revenue in USD Million, 2018 - 2030)
Low Frequency
High Frequency
Pulse Electromagnetic Field Therapy Devices Application Outlook (Revenue in USD Million, 2018 - 2030)
Pain Management
Bone Growth
Others
Pulse Electromagnetic Field Therapy Devices End-use Outlook (Revenue in USD Million, 2018 - 2030)
Hospitals
Home Care Settings
Others
Pulse Electromagnetic Field Therapy Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Thailand
Australia
South Korea
Latin America
Brazil
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in Pulse Electromagnetic Field Therapy Devices Market
Bedfont Scientific Ltd.
Orthofix Medical Inc.
I-Tech Medical Division
Oska Wellness
Medithera
NiuDeSai
Nuage Health
Oxford Medical Instruments Health Store
Bemer USA, LLC
"The quality of research they have done for us has been excellent..."